Long-term survival and interruption of HAART in HIV-related pulmonary hypertension

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 24, Issue 2, 2005, Pages 153-155

  Zinkernagel, A S ^a   Von Overbeck, J ^a   Opravil, M ^a   Jenni, R ^a   Speich, R ^a   Mueller, N J ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DIDANOSINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EFAVIRENZ; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; ILOPROST; INDINAVIR; ISOSORBIDE DINITRATE; LAMIVUDINE; NEVIRAPINE; PHENPROCOUMON; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CELL COUNT; DISEASE COURSE; ECHOCARDIOGRAPHY; FOLLOW UP; HEADACHE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; MALE; PARAMETER; PATIENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG ADMINISTRATION SCHEDULE; HIV INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; MALE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 16844367823     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-005-1289-7     Document Type: Article

References (10)

1. Speich R, Jenni R, Opravil M, Pfab M, Russi EW (1991) Primary pulmonary hypertension in HIV infection. Chest 100:1268-1271
2. Opravil M, Pechere M, Speich R, Joller-Jemelka HI, Jenni R, Russi EW, Hirschel B, Luthy R (1997) HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med 155:990-995
3. Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA (2000) HIV-related pulmonary hypertension: analytic review of 131 cases. Chest 118:1133-1141
4. Pellicellii AM, D'Ambrosio C, Vizza CD, Borgia MC, Tanzi P, Pino P, Zachara E, Soccorsi F (2004) HIV-related pulmonary hypertension. From pathogenesis to clinical aspects. Acta Cardiol 59:323-330
5. Klings ES, Farber HW (2003) The pathogenesis of HIV-associated pulmonary hypertension. Adv Cardiol 40:71-82
6. Cool CD, Rai PR, Yeager ME, Hernandez-Saavedra D, Serls AE, Bull TM, Geraci MW, Brown KK, Routes JM, Tuder RM, Voelkel NF (2003) Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med 349:1113-1122
7. Alp S, Schlottmann R, Bauer TT, Schmidt WE, Bastian A (2003) Long-time survival with HIV-related pulmonary arterial hypertension: a case report. Aids 17:1714-1715
8. Ricciardi MJ, Rubenfire M (1999) How to manage primary pulmonary hypertension. Giving hope to patients with a life-threatening illness. Postgrad Med 105:45-48, 51-46
9. Sitbon O, Gressin V, Speich R, Macdonald PS, Opravil M, Cooper DA, Fourme T, Humbert M, Delfraissy JF, Simonneau G (2004) Bosentan for human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 170:1212-1217
10. Zuber JP, Calmy A, Evison JM, Hasse B, Schiffer V, Wagels T, Nuesch R, Magenta L, Ledergerber B, Jenni R, Speich R, Opravil M (2004) Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 38:1178-1185